All the latest news on the marijuana space delivered directly to your inbox.
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews

InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.

13x13x1 READ MORE
Cannabis Wheaton Announces Strategic Alliance With Large Convenience Store Group

Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) announceS that it has entered an exclusive strategic alliance with the corporate owner of a national chain of convenience stores to develop and implement cannabis distribution and retail sale opportunities at all Convenience Store Group locations.

13x13x1 READ MORE
Aurora Cannabis Announces $6 Million Private Placement

Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").

13x13x1 READ MORE
Emblem Announces $25 Million Bought Deal

Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase 5,714,300 units (the "Units") and 15,000 convertible unsecured debentures of the Company

13x13x1 READ MORE
Please see full disclaimers on the website applicable to all content provided by TSI, wherever published or re-published:

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

32x32x1   32x32x2
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.